Clinical trial

A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis

NCT02281552

Study summary

ClinicalTrials.gov

A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Tofacitinib Normalized identity: tofacitinib View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-11-18

PhasePHASE3

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

TofacitinibDRUG · verified · RxNorm: tofacitinib

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

FukuokaJapan2 NagoyaAichi-ken, Japan2 SaitamaJapan2 ŌitaJapan2 AsahikawaHokkaido, Japan2 MoriokaIwate, Japan2 YokohamaKanagawa, Japan1 KyotoJapan1 ChibaJapan1 KumamotoJapan1 KanagawaJapan1 SendaiMiyagi, Japan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02281552 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.